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Results: There was no significant difference between QT end interval, JT
interval and TDR at baseline and after implant with different pacing modes.
Conclusion: In our study, we noticed no effect of pacing modes on repo-
larization in patients with heart failure. The high incidence of sudden death
observed in CRT may be explained by competitvity of modes of death rather
than induced abnormal repolarization.
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Does continuous assessment of heart rate variability by devices
provide prognostic information in cardiac resynchronization the-
rapy patients?
Celine Goeminne
Hôpital cardiologique, cardiologie C, Lille Cedex, France
Background: Heart failure remains a severe disease with high mortality
despite pharmologic treatment and new successful therapy options such as car-
diac resynchronization therapy (CRT). Heart rate variability (HRV), which
reflects autonomic nervous system function, is a prognostic marker in chronic
heart failure. It can be easily and continuously assessed by CRT devices but
its prognostic value is not well known in these patients.
Methods: The relationship between HRV and morbimortality was exam-
ined in a retrospective study concerning 34 patients who received CRT devices
between july 2002 and february 2008. HRV footprint and standard deviation
of averaged normal R to R intervals (SDANN) was continuously measured by
devices.
Results: The study showed an overall improvement in SDANN (71,8 ±
18,3 to 87,6 ± 29 ms, p=0,002) and HRV footprint (33,5 ± 9,2 to 37,5 ± 9%,
p=0,013) after resynchronization. During a median of 17,7 months of follow
up, 26% (9/34) patients died or were hospitalised for acute heart failure.
SDANN and HRV foorprint at the time of device implantation were not pre-
dictors of morbimortality. Improvement of SDANN > 5% after resynchroniza-
tion was predictor of survival free from event (p<0,0001).
Conclusion: Continuous assessment of SDANN by devices may be a
useful tool for risk stratification in CRT patients.
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Background: Radiofrequency (RF) isolation of pulmonary veins (PVs) has
emerged as an effective treatment for patients presenting drug refractory atrial
fibrillation (AF). The objective of this study was to assess the feasibility,
safety, and short-term outcome of pulmonary vein isolation (PVI) in parox-
ysmal and persistent AF patients with a new cryoballoon catheter technique
(Arctic Front, Cryocath, Quebec, Canada).
Methods: Between December 2007 and April 2009, 37 patients (25
males, mean age 56 years old) with symptomatic, drug refractory, parox-
ysmal (n= 36) or persistent (n= 1) AF underwent circumferential antral
PVI using a double lumen 23 or 28 mm cryoballoon catheter. Before dis-
charge, all patients were subjected to 24-hour Holter electrocardiograms,
echocardiography, and esophageal endoscopy. In case of symptomatic
recurrences, a second AF ablation aiming at PV isolation, was performed
using RF catheter.
Results: Out of 148 treated veins, 140 were completely isolated (94.6 %).
All PVs were completely isolated in 28/37 patients (75.6 %). The number of bal-
loon applications per vein was 2.18 ± 0.69. The mean procedure and fluoroscopy
time were 164.8 ± 39.3 and 32.4 ± 12.3 min respectively. Thirty-one patients
were free of AF at hospital discharge (83.8 %). No PV narrowing, atrio-esoph-
ageal fistula or thromboembolic event occurred. Three phrenic nerve palsy
(8.1%) were observed after cryoapplication at the right superior PV. Two of
them resolved immediately after cessation of cryoenergy, one resolved at 2
weeks. The most frequent complications were pericardial effusions (n=8) and
groin hematoma (n= 3) or ecchymosis (n=6), all spontaneously reversible.
Among the 15 patients seen at 4 months follow-up, all were AF free after one
(n = 11) or two procedures (n= 4) without any antiarythmic drugs.
Conclusion: Cryoballoon PVI appears as an effective and safe technique
with a relatively high clinical success rate at short-term follow-up.
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Evaluation of Syncope in Brugada Syndrome: The Effect on Outcome Risk
stratification in pts with Brugada syndrome (BS) is difficult. The report from the
2nd Consensus Committee on BS suggests that all pts with syncope without a
“clear extracardiac cause” should have an implantable cardioverter-defibrillator
(ICD). However a clear cause for syncope may be difficult to prove.
Methods: All pts diagnosed with BS at Bordeaux CHU between 1999 and
2009 have been enrolled in a prospective registry. All patients with syncope
were enrolled in the present study (Group 1 without and Group 2 with a “clear
extracardiac cause” of syncope). Patients were followed in the clinic or by
phone annually unless there was an event.
Results: Of 185 pts with BS, 49 (39 male, 47 ±12yo) had at least one syn-
cope. All 27 pts in group 1 received an ICD. Of the 22 pts in group 2, 4
received an implantable loop recorder [MJW1] (ILR) and 1 patient received an
ICD after positive EP study.
With a mean follow-up of 53 ±38 months, 19 pts were asymptomatic, 5 had
appropriate ICD therapy, 2 patients had further syncopal events not associated
with cardiac arrhythmia and 1 pt died of a non cardiac cause in group 1. In
group 2, 14pts were asymptomatic, 5 had recurrent atypical syncopal events
(without arrhythmia shown by ILR in 3 pts), 2 experienced atypical chest pain
and 1 died of drug abuse.
Conclusions: Diagnosis of syncope is difficult, and 7% of BS pts pre-
senting with syncope without a clear cardiac cause will have further events
without cardiac arrhythmia. Better evaluation of syncope is required to spare
pts unnecessary ICDs. 
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  group 1
27 patients
syncope 
without a clear 
extracardiac cause
 group 2 
22 patients
syncope 
with a clear 
extracardiac cause
p 
gender (male)  21 (80.8 %)  18 (78.3 %)  0.83
age (years old)  48 (+/- 12.2)  45 (+/- 11)  0.39
follow-up (months)  53 (+/- 36.1)  52 (+/- 42.3)  0.90
spontaneous type 1 ECG  21 (80.8 %)  13 (56.5 %)  0.07
 EP Study:
– positive
– negative
– not done
 8 (29.7 %)
13 (48 %)
6 (22.3 %)
 1 (4.5 %)
17 (77.3 %)
4 (18.2 %)
 0.06
circunstances of diagnosis:
– unexpected finding
– familial assessment
– syncope
 
4 (14.8 %)
2 (7.4 %)
21 (77.8 %)
 
7 (31.8 %)
2 (9.1 %)
13 (59.1 %)
 0.43
